Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer: Multicentre, Open-label,Phase 1B Safety Study

Trial Profile

Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer: Multicentre, Open-label,Phase 1B Safety Study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs Donafenib (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Sponsors Suzhou Zelgen Biopharmaceuticals
  • Most Recent Events

    • 04 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 07 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top